Showing 301-310 of 5313 results for "".
Evolutions and Revolutions in HS
https://practicaldermatology.com/topics/rare-disease/evolutions-and-revolutions-in-hs/19726/The past decade has seen significant advances in the understanding of hidradenitis suppurativa pathogenesis, informing research into novel treatment approaches, such as biologics, and expanded indications for existing pharmacologic agents. Ali Alikhan, MD reviews the evolving landscape in HS and revA Day in the Life: How Patient Engagement Technology Can Help Improve Care Delivery
https://practicaldermatology.com/topics/practice-management/a-day-in-the-life-how-patient-engagement-technology-can-help-improve-care-delivery/23170/Choosing the right tools can improve patient flow, support adherence, and provide enhanced satisfaction.Enduring Success
https://practicaldermatology.com/topics/practice-management/enduring-success/20672/Make sure your practice does everything it can to satisfy and retain employees.To Attenuate the Skin Cancer Epidemic, Start Early
https://practicaldermatology.com/topics/skin-cancer-photoprotection/to-end-the-skin-cancer-epidemic-start-early/20719/UV education and good SPF habits for children are essential to reversing worrisome skin cancer trends.Enbrel Gets Nod for Pediatric PsO; IL-33 Targeted in Itch
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enbrel-gets-nod-for-pediatric-pso-il-33-targeted-in-itch/18562/FDA approved Amgen's Enbrel (etanercept) for chronic moderate to severe psoriasis in pediatric patients age 4 to 17. DermCheck App partners with anti-bullying groups Pacer and Not In My Town to help fight bullying and expand acne care. Researchers show that anti-IL-33 antibody reduces itch of poisonElections and Markets, Encore and Biofrontera Launches, More
https://practicaldermatology.com/topics/practice-management/dermwiretv-elections-and-markets-encore-and-biofrontera-launches-more/18564/Election years bring market uncertainty, but should you be making any changes to your portfolio now? Financial experts weigh in on why—no matter the results—there's no need for panic. Allergan launches a new campaign, ActuallySheCan, to empower young women. Several new products are now available forPapa in at Valeant, J&J Acquires Neostrata, Celebrity Lip Envy
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-papa-in-at-valeant-j-j-acquires-neostrata-celebrity-lip-envy/18772/This edition of DermWireTV brings news that Joseph C. Papa has left Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, to take the helm as CEO at Valeant Pharmaceuticals. He will replace J. Micheal Pearson. Valeant also concluded its investigation arouThe State of Dermatology Entrepreneurship 2015
https://practicaldermatology.com/topics/practice-management/the-state-of-dermatology-entrepreneurship-2015/18913/William Ju, MD, President of Advancing Innovation in Dermatology talks about entrepreneurship in dermatology. Where are new ideas, technologies, and therapies coming from, and how will they move ahead? Dr. Ju talks about the role of the pharmaceutical industry and finding resources.Cynosure Acquires Ellman International
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cynosure-acquires-ellman-international/19059/Cynosure Acquires Assets of Ellman International, NPF Ramps Up Patient Advocacy, New App Available for Practice, PLUS: Acne Insights.A State of Transition for EHRs
https://practicaldermatology.com/topics/practice-management/a-state-of-transition-for-ehrs/22953/As practitioners await the next step in the larger implementation of this technology, an emphasis on utility is more important than ever.